- Publication also documents the ability to deliver targeted thrombolytic medication via IRRAflow's recurring irrigation for the first time in peer-reviewed scientific literature STOCKHOLM, May 28, ...
17don MSN
ClearPoint forecasts $52m-$56m 2026 revenue range as IRRAflow could be cash neutral as early as 2027
Q1 2026 Management View “Our company has started 2026 on a strong note by achieving record revenue of $12.1 million for the quarter,” and this was “driven primarily by organic devices growth of 25%,” ...
The latest generation of IRRAflow was launched in Europe in the first quarter of this year after securing the product's CE Mark certification in December 2019. The covid-19 pandemic slowed the launch ...
ClearPoint Neuro (NASDAQ:CLPT) reported record first-quarter 2026 revenue and reaffirmed its full-year outlook, as management ...
IRRAS is a global medical care company focused on delivering innovative medical solutions to improve the lives of critically ill patients. IRRAS designs, develops, and commercializes neurocritical ...
LOS ANGELES, Calif. (Ivanhoe Newswire) – It’s the type of brain bleed medical experts say killed comedian Bob Saget in January. A subdural hematoma can happen when someone falls and hits their head or ...
STOCKHOLM, Dec. 9, 2019 /PRNewswire/ -- IRRAS AB (NASDAQ Stockholm: IRRAS), a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced today ...
STOCKHOLM, March 25, 2020 /PRNewswire/ -- IRRAS, a global medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced a long-term ...
ClearPoint Neuro’s latest earnings call painted a largely upbeat picture, with record quarterly revenue, expanding margins and meaningful progress on product and regulatory fronts. Management ...
ClearPoint forecasts $52m-$56m 2026 revenue range as IRRAflow could be cash neutral as early as 2027
“We… continue to expect 2026 revenue to be in the range of $52 million to $56 million” (President, CEO & Director Burnett). “In 2026, we expect all 4 of these ...
Neurosurgeons from the Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, published data in the March issue of Operative Neurosurgery that compared procedural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results